The business itself is genuinely strong: revenue growing about 10%, net margins near 15%, a moderate competitive moat.
The valuation lens
Our framework labels the valuation MODERATE. Fair value lands near $619 against a $578 share price, a margin of safety of about 7%. The trailing multiple sits around 31 times earnings, which only makes sense if the growth holds.
The two standards split: it clears the faith-based (AAOIFI) screen but not our broader anchor screen. We default to protection and do not call it compliant on a divergence.
The compliant alternative
If the theme is what draws you, ICON Public Limited Company (ICLR) sits in the same industry (Diagnostics & Research) and clears our principled screen, the place to look instead of chasing a name that does not.
The verdict for a values-conscious investor
A beat-and-raise does not change the screen. This is a great company you can admire without owning, protection first. We do not confuse a strong quarter with a suitable holding.
This is analysis, not financial advice. Always manage your risk.
How This Entry Scores
Every level named in a session brief is scored against the next scheduled close. Nothing is edited after filing: if a level breaks, the record shows it as filed, not as corrected. The desk's full scored history sits on the track record page.